Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China-A Test-Negative Case-Control Study.

He, Tingjuan; Wang, Meixia; Mi, Hongfei; Xu, Liansheng; Lu, Wenkui; Ouyang, Xue; Guo, Zhinan; Su, Chenghao

He, Tingjuan; Wang, Meixia; Mi, Hongfei; Xu, Liansheng; Lu, Wenkui; Ouyang, Xue; Guo, Zhinan; Su, Chenghao.

Afiliación

He T; School of Public Health, Xiamen University, Xiamen 361102, China.
Wang M; Department of Infection Control, Xiamen Clinical Research Center for Cancer Therapy, Xiamen 361015, China.
Mi H; Department of Infection Control, Xiamen Clinical Research Center for Cancer Therapy, Xiamen 361015, China.
Xu L; Xiamen Center for Disease Control and Prevention, Xiamen 361021, China.
Lu W; Xiamen Center for Disease Control and Prevention, Xiamen 361021, China.
Ouyang X; Tong'an District Center for Disease Control and Prevention, Xiamen 361021, China.
Guo Z; Xiamen Center for Disease Control and Prevention, Xiamen 361021, China.
Su C; Department of Infection Control, Xiamen Clinical Research Center for Cancer Therapy, Xiamen 361015, China.

Vaccines (Basel) ; 11(3)2023 Feb 23.

Article en En | MEDLINE | ID: mdl-36992116

Palabras clave

COVID-19; Delta variant; test-negative casecontrol design; vaccine effectiveness

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google